AUTHOR=Xiao Fenglai , Caciagli Lorenzo , Wandschneider Britta , Joshi Bhavini , Vos Sjoerd B. , Hill Andrea , Galovic Marian , Long Lili , Sone Daichi , Trimmel Karin , Sander Josemir W. , Zhou Dong , Thompson Pamela J. , Baxendale Sallie , Duncan John S. , Koepp Matthias J. 

TITLE=Effect of Anti-seizure Medications on Functional Anatomy of Language: A Perspective From Language Functional Magnetic Resonance Imaging

JOURNAL=Frontiers in Neuroscience

VOLUME=15

YEAR=2022

URL=https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2021.787272

DOI=10.3389/fnins.2021.787272

ISSN=1662-453X

ABSTRACT=<sec><title>Background</title><p>In epilepsy, cognitive difficulties are common, partly a consequence of anti-seizure medications (ASM), and cognitive side-effects are often considered to be more disabling than seizures and significantly affect quality of life. Functional MRI during verbal fluency tasks demonstrated impaired frontal activation patterns and failed default mode network deactivation in people taking ASM with unfavourable cognitive profiles. The cognitive effect of ASMs given at different dosages in monotherapy, or in different combinations, remains to be determined.</p></sec><sec><title>Methods</title><p>Here, we compared the effects of different drug loads on verbal fluency functional MRI (fMRI) in people (i) taking dual therapy of ASMs either considered to be associated with moderate (levetiracetam, lamotrigine, lacosamide, carbamazepine/oxcarbazepine, eslicarbazepine, valproic acid; <italic>n</italic> = 119, 56 females) or severe (topiramate, zonisamide) side-effects; <italic>n</italic> = 119, 56 females), (ii) taking moderate ASMs in either mono-, dual- or triple-therapy (60 subjects in each group), or (iii) taking different dosages of ASMs with moderate side-effect profiles (<italic>n</italic> = 180). “Drug load” was defined as a composite value of numbers and dosages of medications, normalised to account for the highest and lowest dose of each specific prescribed medication.</p></sec><sec><title>Results</title><p>In people taking “moderate” ASMs (<italic>n</italic> = 119), we observed higher verbal-fluency related to left inferior frontal gyrus and right inferior parietal fMRI activations than in people taking “severe” ASMs (<italic>n</italic> = 119). Irrespective of the specific ASM, people on monotherapy (<italic>n</italic> = 60), showed greater frontal activations than people taking two (<italic>n</italic> = 60), or three ASMs (<italic>n</italic> = 60). People on two ASMs showed less default mode (precuneus) deactivation than those on monotherapy. In people treated with “moderate” ASMs (<italic>n</italic> = 180), increased drug load correlated with reduced activation of language-related regions and the right piriform cortex.</p></sec><sec><title>Conclusion</title><p>Our study delineates the effects of polytherapy and high doses of ASMs when given in monotherapy on the functional anatomy of language. Irrespective of the cognitive profile of individual ASMs, each additional ASM results in additional alterations of cognitive activation patterns. Selection of ASMs with moderate cognitive side effects, and low doses of ASMs when given in polytherapy, could reduce the cognitive effect.</p></sec>